FDA Clearance Tracker · P930014-S069
ACRYSOF INTRAOCULAR LENS
Last checked: Nov 20, 2026Latest source record: Apr 28, 2014 (this decision)Source: openFDAMethods & limitations
Decided
Apr 28, 2014
Approved
Time to decision
271 days
Received Jul 31, 2013. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P930014-S069
- Device name
- ACRYSOF INTRAOCULAR LENS
- Applicant
- Alcon Laboratories, Inc.
- Applicant location
- Fort Worth, TX
- Received
- Jul 31, 2013
- Decided
- Apr 28, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P930014
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THREE ALTERNATE POLYPROPYLENE MATERIALS, BASELL PD702, EXXON ACHIEVE 1605, AND EXXON PP1105E1, FOR INTRAOCULAR LENS (IOL) DEVICE PRIMARY PACKAGING.
Source documents
Other decisions for Alcon Laboratories, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.